Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients

R.J. Manders, S.F.E. Praet, R.C.R. Meex, R. Koopman, A.L. de Roos, A.J. Wagenmakers, W.H. Saris, L.J. van Loon

Research output: Contribution to journalArticleAcademicpeer-review

40 Citations (Scopus)
Original languageEnglish
Pages (from-to)2721-2722
JournalDiabetes Care
Volume29
Issue number12
DOIs
Publication statusPublished - 1 Jan 2006

Cite this

Manders, R. J., Praet, S. F. E., Meex, R. C. R., Koopman, R., de Roos, A. L., Wagenmakers, A. J., Saris, W. H., & van Loon, L. J. (2006). Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients. Diabetes Care, 29(12), 2721-2722. https://doi.org/10.2337/dc06-1424